Published in Am J Pediatr Hematol Oncol on January 01, 1991
Treatment of severe aplastic anemia using HLA-non-identical family donors. Am J Pediatr Hematol Oncol (1991) 0.75
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol (1987) 2.81
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group. J Clin Oncol (1993) 1.79
Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res (1985) 1.78
Is more better? Dose intensity in neuroblastoma. J Clin Oncol (1991) 1.51
Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol (1993) 1.49
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood (1986) 1.42
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant (1998) 1.10
Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow. Cancer Res (1985) 1.10
Infectious mononucleosis prior to acute leukemia: a possible role for the Epstein-Barr virus. Cancer (1972) 1.05
Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion (1983) 1.04
Autonomous production of parathyroid hormone by lymphoblastic leukemia cells in culture. J Pediatr (1979) 1.01
Acute hemorrhage into Wilms tumor: a cause of rapidly developing abdominal mass with hypertension, anemia, and fever. J Pediatr (1977) 1.01
The nature of childhood leukemia and lymphoma. Am J Pathol (1978) 1.00
B and T cell lymphomas. Analysis of blood and lymph nodes in 87 patients. Am J Med (1975) 1.00
Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc (2001) 0.99
Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies. J Clin Oncol (1986) 0.98
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. J Clin Oncol (1983) 0.95
Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement. Am J Pediatr Hematol Oncol (1986) 0.95
Sclerodermatous graft-versus-host disease limited to an area of measles exanthem. Lancet (1978) 0.94
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group. J Clin Oncol (1991) 0.94
Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report. J Clin Oncol (1993) 0.93
Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation. Am J Med (1980) 0.93
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol (1989) 0.92
Prognostic significance of surface marker analysis in childhood non-Hodgkin's lymphoproliferative malifnancies. Am J Hematol (1976) 0.90
Lymphocytes bearing receptors for both sheep erythrocytes and complement in patients with neoplastic and non-neoplastic diseases. Clin Immunol Immunopathol (1977) 0.90
Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report. J Clin Oncol (1994) 0.89
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant (1989) 0.89
Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood (1980) 0.89
Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognoses. Am J Clin Pathol (1979) 0.89
Neonatal neutropenia. Clinical manifestations, cause, and outcome. Am J Dis Child (1988) 0.88
Transient blueberry muffin appearance of a newborn with congenital monoblastic leukemia. J Am Acad Dermatol (1989) 0.87
Malignant osteopetrosis: a disease of abnormal osteoclast proliferation. Metab Bone Dis Relat Res (1981) 0.86
Renal and metabolic complications of childhood non-Hodgkin's lymphoma. Semin Oncol (1977) 0.86
Trisomy 21 in bone marrow cells of a patient with a prolonged preleukemic phase. Med Pediatr Oncol (1980) 0.86
Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis (1986) 0.86
Oncornavirus-like particles from cultured bone marrow cells preceding leukemia and malignant histiocytosis. Proc Natl Acad Sci U S A (1975) 0.86
Roentgenographic features of American Burkitt's lymphoma. Radiology (1977) 0.84
Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol (1978) 0.84
Diagnostic imaging of human neuroblastoma with radiolabeled antibody. Radiology (1986) 0.84
Cells that resorb bone. N Engl J Med (1984) 0.83
Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer (1980) 0.83
A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia. J Pediatr (1982) 0.83
Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group. J Clin Oncol (1989) 0.83
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med (1991) 0.83
Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation. Bone Marrow Transplant (1991) 0.82
Bone marrow transplantation in Hunter syndrome: a preliminary report. Birth Defects Orig Artic Ser (1986) 0.82
The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia. Cancer (1977) 0.82
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood (1992) 0.82
Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents. J Clin Oncol (1999) 0.82
Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang (1985) 0.82
Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. Blood (2001) 0.82
Buffy coat transfusions in neutropenic neonates with presumed sepsis: a prospective, randomized trial. Pediatrics (1987) 0.81
Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatr Dent (1987) 0.81
Histiocytosis X presenting as a primary penile lesion. J Urol (1981) 0.81
Mitogenic response to Toxocara antigen and chemotactic defect in visceral larva migrans. Am J Dis Child (1980) 0.81
Factor V deficiency in Philadelphia-positive chronic myelogenous leukemia. Blood (1980) 0.80
The metabolism of chlorpromazine by liver microsomal enzyme systems. J Pharmacol Exp Ther (1967) 0.80
The Philadelphia chromosome in acute leukemia. Virchows Arch B Cell Pathol (1978) 0.80
Barrett's esophagus in three children after antileukemia chemotherapy. Cancer (1987) 0.80
Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol (1987) 0.80
Reduction of contact factors in sickle cell disease. J Pediatr (1985) 0.79
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy. Bone Marrow Transplant (1991) 0.79
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients. Am J Pediatr Hematol Oncol (1985) 0.78
Transfusion of patients undergoing bone marrow transplantation. Hum Pathol (1983) 0.78
Developmental orofacial deficits associated with multimodal cancer therapy: case report. Pediatr Dent (1989) 0.78
Philadelphia chromosome positive childhood acute lymphoblastic leukemia. Blood (1980) 0.78
Neutrophil elastase produces 52-kD and 30-kD glucocorticoid receptor fragments in the cytosol of human leukemia cells. Blood (1987) 0.77
Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients. Cancer (1993) 0.77
Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy. Am J Pediatr Hematol Oncol (1980) 0.77
Acute lymphoblastic leukemia of NK-cell lineage: responses to IL-2. Leuk Res (1989) 0.77
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome. J Hematother (1997) 0.77
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies. Exp Hematol (1995) 0.77
Characterization of the blast cell in childhood non-Hodgkin's lymphoproliferative malignancies. Semin Oncol (1977) 0.77
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients. Blood (1984) 0.76
Oral complications associated with bone marrow transplantation in a pediatric population. Am J Pediatr Hematol Oncol (1983) 0.76
Pharmacokinetic study of indicine N-oxide in pediatric cancer patients. Cancer Chemother Pharmacol (1982) 0.76
Reassessment of patient response to monoclonal antibody 3F8. J Clin Oncol (1992) 0.76